Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Sep - Newspaper Advertisement for special window for relodgement of transfer requests of physical shares
Source: Bse
Chemicals stocks · Micro cap · NSE
Rallis India Limited empowers farmers with innovative solutions from seed to harvest. Its portfolio includes crop protection (herbicides, insecticides, fungicides), soil & plant health (organic/bio-fertilizers), and seeds (Rice, Bajra, Maize, Cotton & Mustard). The company operates B2C, B2B, and Custom Synthesis Manufacturing segments.
SMA20 -3.2% / mo · MACD + · near 52W low · sector -4.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +6.8% · PAT +31.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +7% YoY · PAT +32% YoY · margin expansion · +124% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,022 Cr | +6.8% | +124.1% |
| EBITDA | ₹185 Cr | +23.3% | +18600.0% |
| Operating margin | 18.0% | +200 bps | +1820 bps |
| PAT | ₹125 Cr | +31.6% | NDF |
| PAT margin | 12.2% | +230 bps | +1552 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 55. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 38 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Rallis India reported a 7% YoY revenue growth to Rs. 1,022 Cr in Q1 FY27, driven by strong domestic formulation placement. EBITDA grew 23% YoY to Rs. 184 Cr, and PAT increased 31% YoY to Rs. 125 Cr, despite a tough operating environment.
The company delivered resilient Q1 FY27 results with strong EBITDA and PAT growth, primarily driven by domestic B2C crop protection. While B2B exports and CSM faced declines, new product launches and strategic focus on underserved segments and SPH indicate continued efforts to drive future growth despite market headwinds.
Topline growth of 7% driven by strong placement and campaign activities across key markets in domestic formulation.
Overcoming challenges, B2C business delivered 19% revenue growth.
Launched 3 new products during 1QFY27 (2 Herbicides, 1 Insecticide) and 9 products across Cotton, Millet, and Paddy in Seeds business.
Soil & Plant Health business registered volume growth in select key products through pre-placement.
Domestic formulations growth driven by aggressive preplacement, liquidation efforts, and drive for volume scale up.
Digital marketing interventions continue to promote products through Anubandh Edge Schemes, Farmers QR Code/ Reward Schemes, and Sampark+.
Overall demand was subdued with driest June in last 12 years, delayed Kharif sowings, crop shifts and reduction in cotton acreages.
Industry impacted by war situation, leading to panic buying of commodities with significant price increases.
Trade channels rushed to secure fertilizer, resulting in cash crunch for Crop Protection causing conservative inventory stocking and slower liquidation.
Extensive spread of illegal HTBT cotton contributed to reduction in cotton acreages.
Delayed monsoon and Kharif sowings highlight reliance on weather patterns for agricultural demand.
Farmer crop switch and crop shift among other challenges indicate demand volatility.
War situation in West Asia impacted planning and led to significant price increases for commodities.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Agriculture is a seasonal business, and Q1 results are best compared to the same quarter in the previous year to account for seasonal variations in demand, sowings, and market conditions.
Revenue increased by 7% from Rs. 957 Cr. in Q1FY26 to Rs. 1,022 Cr in Q1FY27.
EBITDA increased by 23% from Rs. 150 Cr. in Q1FY26 to Rs. 184 Cr. in Q1FY27.
PAT increased by 31% from Rs. 95 Cr. in Q1FY26 to Rs. 125 Cr. in Q1FY27.
Q1FY27 Crop Protection B2C revenue increased by 19% vs Q1FY26.
Management aims to widen reach, extend portfolio offerings, build strategic alliances, and focus on underserved crop protection segments.
Mission includes accelerating innovation to market and targeting R&D investments.
Management is focused on driving operational excellence and cost competitiveness.
Leveraging digital, collaborations, and alliances, with a core value of customer centricity.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Domestic B2C Growth | 19% revenue growth YoY in Q1FY27. | Sustained double-digit growth and market share gains in domestic formulations. |
| New Product Pipeline | Launched 3 new products in Crop Protection and 9 in Seeds in Q1FY27. | Successful commercialization and revenue contribution from new launches. |
| B2B/CSM Performance | B2B exports including CSM revenue declined by 16% YoY. | Recovery in international demand and improved unit margins in B2B/CSM segments. |
| Monsoon & Sowing Trends | Delayed monsoon and Kharif sowings impacted Q1. | Favorable monsoon progression and improved Kharif sowings for H2 FY27. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 78th percentile of the scored universe and 64th percentile within Chemicals. Main check: financial discipline is weak at 50/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 64th pctile, median 73 · Micro: 60th pctile, median 73
120 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse